Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

Ad Right Top

Latest News

FDA Rejects J&J’s RA Drug Sirukumab

The U.S. FDA issued a Complete Response Letter calling for additional clinical data to evaluate the safety of Janssen’s rheumatoid arthritis drug sirukumab.

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

August 2017 Focus: Pharma Innovators, Top 200 Meds, Lions Health and more!

Subscribe

Ad Right Bottom

Main Navigation